Status: Recruiting
Valved Graft PMCF Study
Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.
Participants needed: 260
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Abbott Medical DevicesUpdated: Apr 13, 2026Locations: 25
Eligibility criteria
cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthet...
anticoagulation therapy intolerant [+2]